Your browser doesn't support javascript.
loading
The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.
Schiffman, Mark; Mirabello, Lisa; Egemen, Didem; Befano, Brian; Xiao, Yanzi; Wentzensen, Nicolas; Raine-Bennett, Tina; Nayar, Ritu; Cheung, Li C; Rositch, Anne; Beaty, Terri; Perkins, Rebecca B; de Sanjose, Silvia; Lorey, Thomas; Castle, Philip E; Burk, Robert D.
Afiliação
  • Schiffman M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. Electronic address: mark.schiffman@nih.gov.
  • Mirabello L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
  • Egemen D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
  • Befano B; Information Management Services Inc, Calverton, MD, USA.
  • Xiao Y; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
  • Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
  • Raine-Bennett T; Women's Health Research Institute, Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Nayar R; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Cheung LC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
  • Rositch A; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Beaty T; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Perkins RB; Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, MA, USA.
  • de Sanjose S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA; ISGlobal, Barcelona, Spain.
  • Lorey T; Regional Laboratory, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Castle PE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
  • Burk RD; Departments of Pediatrics, Microbiology & Immunology, Epidemiology & Population Health, and Obstetrics, Gynecology & Women's Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Gynecol Oncol ; 174: 253-261, 2023 07.
Article em En | MEDLINE | ID: mdl-37243996
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Adenocarcinoma / Displasia do Colo do Útero / Neoplasias do Colo do Útero / Infecções por Papillomavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Adenocarcinoma / Displasia do Colo do Útero / Neoplasias do Colo do Útero / Infecções por Papillomavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2023 Tipo de documento: Article